Wikipedia -WSS

Wikipedia

author：fashion 2025-09-03 12:11:03 - browse：8758

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Solve the antibiotic resistance crisis with preventive drugs

hotspot

knowledge

WSS

FDA warns J&J's Abiomed: We will regulate your software

Life sciences deals on track to hit lowest point since 2017

STAT Summit: Michael J. Fox on progress in Parkinson's research

Senate committee scrutinizes Medicare Advantage brokers

STAT Summit: Michael J. Fox on progress in Parkinson's research

Senate committee scrutinizes Medicare Advantage brokers

Wikipedia

Wikipedia

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

First Opinion Podcast: Long Covid needs a new approach

Virginia high school admissions case could be legal follow

FDA warns J&J's Abiomed: We will regulate your software

Medical records are filled with copy

A fraught question for the kids of Alzheimer’s: Is it coming for us?

United colonoscopy coverage change 'may cost lives,' doctors say

Cancer cells are shown to suck energy source from immune cells

Wildfire smoke exposes gaps in outdoor worker protections

Life sciences deals on track to hit lowest point since 2017

explore

Eight reasons why you should get an updated Covid vaccine

Eight reasons why you should get an updated Covid vaccine

Life sciences deals on track to hit lowest point since 2017

Hospital price transparency does save money, advocate argues

STAT Readout: Today's biotech news includes Sana and Amylyx

The explosion of genetic testing requires a new approach

entertainment

hotspot

knowledge

knowledge